Hot search: 2012  drive  payment  pumps  situation  Chinese  2012,  logistics  DHL  health 
 
Home > News > Industries > Content

Bioinvent International Has Secured a US Patent for Its Antibody,Discovery Technology

increase font size  reduce font Add date: 2016-11-30  Hits:17
Core prompt: BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique di

BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously.

The company said that traditional drug discovery methods involve the identification of drugs candidates that bind to known disease targets.

The technology has been used in several proprietary discovery projects, while the company provides the technology and also traditional antibody discovery screening to commercial partners.

BioInvent vice president Preclinical Research Bjrn Frendeus said, "With billions of binders available in the libraries and state-of-the-art in vitro and in vivo cancer and immunological assays, we can discover antibodies with the very best properties for onward development."

The company is mainly focused on discovery and development of new antibody-based drugs against cancer and its pipeline currently includes three product candidates for the treatment of cancer.

?

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed
 
中国体育彩票官网体彩7星彩 20选5胆拖投注表 北京快乐8全额提现能到账吗 快乐8压大小的方法 上证380指数 手机麻将游戏排名前十 六肖中特结果 凤凰彩票app幸运赛车 20647如意彩公开一肖 黑龙江36选7app 精准三头六尾中特默认